Serum activity of platelet-activating factor acetylhydrolase is a potential clinical marker for leptospirosis pulmonary hemorrhage

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Yang, Junwei ^a   Zhang, Yixuan ^b   Xu, Jing ^c,d   Geng, Yan ^b   Chen, Xiaoying ^b   Yang, Hongliang ^c,h   Wang, Shengnian ^e   Wang, Hengan ^c   Jiang, Xucheng ^c   Guo, Xiaokui ^c   Zhao, Guoping ^a,e,f,g  

^a INSTITUTE OF PLANT PHYSIOLOGY AND ECOLOGY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

^e NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI   (China)

^f CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BACTERIAL PROTEIN; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GERBIL; HUMAN; IMMUNOPRECIPITATION; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; LUNG HEMORRHAGE; MALE; MASS SPECTROMETRY; MONITORING; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLASMID; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BLEEDING; BLOOD; ENZYMOLOGY; LEPTOSPIRA; LUNG DISEASE; MICROBIOLOGY; PATHOLOGY;

BOVINAE; LEPTOSPIRA INTERROGANS; MERIONES UNGUICULATUS;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; GERBILLINAE; HEMORRHAGE; LEPTOSPIRA; LEPTOSPIROSIS; LUNG DISEASES;

EID: 58449095901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004181     Document Type: Article

References (47)

1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, et al. (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3: 757-771.
2. Vinetz JM (2001) Leptospirosis. Curr Opin Infect Dis 14: 527-538.
3. Levett PN (2001) Leptospirosis. Clin Microbiol Rev 14: 296-326.
4. Trevejo RT, Rigau-Perez JG, Ashford DA, McClure EM, Jarquin-Gonzalez C, et al. (1998) Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis 178: 1457-1463.
5. Zaki SR, Shieh WJ (1996) Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. The Epidemic Working Group at Ministry of Health in Nicaragua. Lancet 347: 535-536.
6. Im JG, Yeon KM, Han MC, Kim CW, Webb WR, et al. (1989) Leptospirosis of the lung: radiographic findings in 58 patients. AJR Am J Roentgenol 152: 955-959.
7. Isogai E, Isogai H, Ito N (1986) Decreased lipopolysaccharide content and enhanced susceptibility of leptospiras to serum leptospiricidal action and phagocytosis after treatment with diphenylamine. Zentralbl Bakteriol Mikrobiol Hyg [A] 262: 438-447.
8. Isogai E, Isogai H, Kurebayashi Y, Ito N (1986) Biological activities of leptospiral lipopolysaccharide. Zentralbl Bakteriol Mikrobiol Hyg [A] 261: 53-64.
9. Alves VA, Gayotto LC, De Brito T, Santos RT, Wakamatsu A, et al. (1992) Leptospiral antigens in the liver of experimentally infected guinea pig and their relation to the morphogenesis of liver damage. Exp Toxicol Pathol 44: 425-434.
10. De Brito T, Prado MJ, Negreiros VA, Nicastri AL, Sakata EE, et al. (1992) Detection of leptospiral antigen (L. interrogans serovar copenhageni serogroup Icterohaemorrhagiae) by immunoelectron microscopy in the liver and kidney of experimentally infected guinea-pigs. Int J Exp Pathol 73: 633-642.
11. Dobrina A, Nardon E, Vecile E, Cinco M, Patriarca P (1995) Leptospira icterohemorrhagiae and leptospire peptidolgycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes. Infect Immun 63: 2995-2999.
12. Bernheimer AW, Bey RF (1986) Copurification of Leptospira interrogans serovar pomona hemolysin and sphingomyelinase C. Infect Immun 54: 262-264.
13. Nally JE, Chantranuwat C, Wu XY, Fishbein MC, Pereira MM, et al. (2004) Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol 164: 1115-1127.
14. Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, et al. (2003) Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 422: 888-893.
15. Sheffield PJ, McMullen TW, Li J, Ho YS, Garrard SM, et al. (2001) Preparation and crystal structure of the recombinant alpha(1)/alpha(2) catalytic heterodimer of bovine brain platelet-activating factor acetylhydrolase Ib. Protein Eng 14: 513-519.
16. Hattori M, Adachi H, Tsujimoto M, Arai H, Inoue K (1994) The catalytic subunit of bovine brain platelet-activating factor acetylhydrolase is a novel type of serine esterase. J Biol Chem 269: 23150-23155.
17. Ho YS, Swenson L, Derewenda U, Serre L, Wei Y, et al. (1997) Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. Nature 385: 89-93.
18. Yukawa M, Mochizuki K, Imamura S (1990) Susceptibility of Mongolian gerbils (Meriones unguiculatus) to leptospires and the protective effect of vaccination. Vet Microbiol 24: 63-71.
19. Branger C, Chatrenet B, Gauvrit A, Aviat F, Aubert A, et al. (2005) Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect Immun 73: 4062-4069.
20. David Randall WB, Kathleen French (2002) Eckert Animal Physiology.
21. Yukawa M, Mochizuki K, Kosaka T, Kamata H, Awaya A, et al. (1994) Protective effects of serum thymic factor to Leptospira interrogans serovar Copenhageni infection in Mongolian gerbils. Vet Microbiol 41: 99-106.
22. Liu G, Jin C, Jin C (2004) CMP-N-acetylneuraminic acid synthetase from Escherichia coli K1 is a bifunctional enzyme: identification of minimal catalytic domain for synthetase activity and novel functional domain for platelet-activating factor acetylhydrolase activity. J Biol Chem 279: 17738-17749.
23. Min JH, Wilder C, Aoki J, Arai H, Inoue K, et al. (2001) Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme. Biochemistry 40: 4539-4549.
24. Manya H, Aoki J, Kato H, Ishii J, Hino S, et al. (1999) Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase. J Biol Chem 274: 31827-31832.
25. Chao W, Olson MS (1993) Platelet-activating factor: receptors and signal transduction. Biochem J 292 (Pt 3): 617-629.
26. Lee C, Sigari F, Segrado T, Horkko S, Hama S, et al. (1999) All ApoBcontaining lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase. Arterioscler Thromb Vasc Biol 19: 1437-1446.
27. Howard KM, Miller JE, Miwa M, Olson MS (1997) Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem 272: 27543-27548.
28. Sorensen J, Kald B, Tagesson C, Lindahl M (1994) Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma. Intensive Care Med 20: 555-561.
29. Memon RA, Fuller J, Moser AH, Feingold KR, Grunfeld C (1999) In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. Am J Physiol 277: R94-103.
30. Gomes RN, Bozza FA, Amancio RT, Japiassu AM, Vianna RC, et al. (2006) Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock 26: 41-49.
31. Nally JE, Whitelegge JP, Bassilian S, Blanco DR, Lovett MA (2007) Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect Immun 75: 766-773.
32. Yasuda PH, Hoshino-Shimizu S, Yamashiro EH, De Brito T (1986) Experimental leptospirosis (L. interrogans serovar icterohaemorrhagiae) of the guinea pig: leptospiral antigen, gamma globulin and complement C3 detection in the kidney. Exp Pathol 29: 35-43.
33. Palaniappan RU, McDonough SP, Divers TJ, Chen CS, Pan MJ, et al. (2006) Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74: 1745-1750.
34. Garofalo P, Cattaneo G (1967) [Description of a case of leptospirosis (probably due to L. icterohemorrhagiae) in a 2-months-old infant]. Minerva Pediatr 19: 1464-1466.
35. Takafuji ET, Kirkpatrick JW, Miller RN, Karwacki JJ, Kelley PW, et al. (1984) An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med 310: 497-500.
36. Guidugli F, Castro AA, Atallah AN (2000) Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev. CD001305.
37. Watt G, Padre LP, Tuazon ML, Calubaquib C, Santiago E, et al. (1988) Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1: 433-435.
38. Graham RM, Stephens CJ, Silvester W, Leong LL, Sturm MJ, et al. (1994) Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit Care Med 22: 204-212.
39. Faine S, Adler B, Bolin C, Perolat P (1999) Leptospira and Leptospirosis.
40. Opal S, Laterre PF, Abraham E, Francois B, Wittebole X, et al. (2004) Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial. Crit Care Med 32: 332-341.
41. Claus RA, Russwurm S, Dohrn B, Bauer M, Losche W (2005) Plasma plateletactivating factor acetylhydrolase activity in critically ill patients. Crit Care Med 33: 1416-1419.
42. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (1997) Plateletactivating factor acetylhydrolases. J Biol Chem 272: 17895-17898.
43. Sambrook J, Fritsch EF, Maniatis T, eds (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
44. Galfre G, Milstein C (1981) Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 73: 3-46.
45. Moon TC, Kim MS, Lee SJ, Lee TY, Kwon SH, et al. (2003) Detection and characterization of 45 kDa platelet activating factor acetylhydrolase in cerebrospinal fluid of children with meningitis. Arch Pharm Res 26: 554-558.
46. He P, He HZ, Dai J, Wang Y, Sheng QH, et al. (2005) The human plasma proteome: analysis of Chinese serum using shotgun strategy. Proteomics 5: 3442-3453.
47. Merien F, Truccolo J, Rougier Y, Baranton G, Perolat P (1998) In vivo apoptosis of hepatocytes in guinea pigs infected with Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol Lett 169: 95-102.